Reata Pharmaceuticals, Inc. Employee Directory
Pharmaceutical ManufacturingTexas, United States51-200 Employees
Reata Pharmaceuticals, Inc. was a pharmaceutical company based in Plano, Texas, focused on developing therapeutics that regulate cellular metabolism and inflammation in serious neurologic diseases. Its pipeline included cemdomespib for diabetic neuropathic pain and Nrf2 activators for neurological diseases. The company operated within the pharmaceutical manufacturing sector and targeted treatments where metabolic and inflammatory pathways contribute to disease. In 2023, Reata was acquired by Biogen, with the acquisition announced as completed. The company's page notes it is no longer updated or monitored and directs readers to Biogen for the latest news.